All Stories

  1. Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections

    Article • Antimicrobial Agents and Chemotherapy, December 2014, ASM Journals

    Peter Pertel

  2. Pharmacokinetics of LFF571 and Vancomycin in Patients with Moderate Clostridium difficile Infections

    Article • Antimicrobial Agents and Chemotherapy, December 2014, ASM Journals

    Peter Pertel

  3. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel spiroindolone KAE609, to assess the safety, tolerability and pharmacokinetics in healthy adult volunteers

    Article • Malaria Journal, September 2014, Springer Science + Business Media

    Peter Pertel

  4. A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers

    Article • Antimicrobial Agents and Chemotherapy, August 2014, ASM Journals

    Peter Pertel

  5. A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers

    Article • Antimicrobial Agents and Chemotherapy, August 2014, ASM Journals

    Peter Pertel

  6. A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study To Assess the Safety and Tolerability of LFF571 in Healthy Volunteers

    Article • Antimicrobial Agents and Chemotherapy, September 2012, ASM Journals

    Peter Pertel

  7. The Value, Qualification, and Regulatory Use of Surrogate End Points in Drug Development

    Article • Clinical Pharmacology & Therapeutics, May 2009, Springer Science + Business Media

    Peter Pertel

  8. The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas

    Article • International Journal of Clinical Practice, March 2009, Wiley

    Peter Pertel

  9. Acute bacterial maxillary sinusitis: time to symptom resolution and return to normal activities with moxifloxacin

    Article • International Journal of Clinical Practice, July 2008, Wiley

    Peter Pertel

  10. Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community‐Acquired Pneumonia

    Article • Clinical Infectious Diseases, April 2008, Oxford University Press (OUP)

    Peter Pertel

  11. Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy

    Article • Journal of Interferon & Cytokine Research, February 2008, Mary Ann Liebert Inc

    Peter Pertel

  12. Complicated Urinary Tract Infections Treated with Extended-Release Ciprofloxacin with Emphasis onPseudomonas aeruginosa

    Article • Journal of Chemotherapy, December 2007, Taylor & Francis

    Peter Pertel

  13. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate

    Article • BJU International, July 2007, Wiley

    Peter Pertel

  14. P2023 Clinical and bacteriological efficacy of sequential intravenous to oral moxifioxacin in hospitalised patients with severe complicated skin and skin structure infections due to Enterobacteriaceae

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Peter Pertel

  15. Randomized Controlled Trial of Moxifloxacin Compared With Piperacillin???Tazobactam and Amoxicillin???Clavulanate for the Treatment of Complicated Intra-abdominal Infections

    Article • Annals of Surgery, August 2006, Wolters Kluwer Health

    Peter Pertel

  16. Risk factors for a poor outcome after therapy for acute pyelonephritis

    Article • BJU International, July 2006, Wiley

    Peter Pertel

  17. Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection

    Article • International Journal of Antimicrobial Agents, November 2005, Elsevier

    Peter Pertel

  18. Clinical Characteristics and Functional Outcomes of West Nile Fever

    Article • Annals of Internal Medicine, September 2004, American College of Physicians

    Peter Pertel

  19. Linezolid Treatment for Osteomyelitis Due to Vancomycin‐Resistant Enterococcus faecium

    Article • Clinical Infectious Diseases, May 2002, Oxford University Press (OUP)

    Peter Pertel

  20. Human Herpesvirus 8 Glycoprotein B (gB), gH, and gL Can Mediate Cell Fusion

    Article • Journal of Virology, May 2002, ASM Journals

    Peter Pertel

  21. Cell Fusion Induced by Herpes Simplex Virus Glycoproteins gB, gD, and gH-gL Requires a gD Receptor but Not Necessarily Heparan Sulfate

    Article • Virology, January 2001, Elsevier

    Peter Pertel

  22. Human Herpesvirus-8 Glycoprotein B Interacts with Epstein–Barr Virus (EBV) Glycoprotein 110 but Fails to Complement the Infectivity of EBV Mutants

    Article • Virology, November 1998, Elsevier

    Peter Pertel

  23. Intractable Hiccups Induced by the Use of Megestrol Acetate

    Article • Archives of Internal Medicine, April 1998, American Medical Association (AMA)

    Peter Pertel

  24. Modified Entry and Syncytium Formation by Herpes Simplex Virus Type 1 Mutants Selected for Resistance to Heparin Inhibition

    Article • Virology, December 1996, Elsevier

    Peter Pertel

  25. Adverse Reactions to Dapsone in Persons Infected with Human Immunodeficiency Virus

    Article • Clinical Infectious Diseases, April 1994, Oxford University Press (OUP)

    Peter Pertel

  26. Risk of Developing Cytomegalovirus Retinitis in Persons Infected With the Human Immunodeficiency Virus

    Article • Retina, January 1993, Wolters Kluwer Health

    Peter Pertel